The ATP-sensitive potassium channel is a key molecular complex for glucose-stimulated insulin secretion in pancreatic  cells. In humans, mutations in either of the two subunits for this channel, the sulfonylurea type 1 receptor (Sur1) or Kir6.2, cause persistent hyperinsulinemic hypoglycemia of infancy. We have generated and characterized Sur1 null mice. Interestingly, these animals remain euglycemic for a large portion of their life despite constant depolarization of membrane, elevated cytoplasmic free Ca 2؉ concentrations, and intact sensitivity of the exocytotic machinery to Ca 2؉ . A comparison of glucose-and meal-stimulated insulin secretion showed that, although Sur1 null mice do not secrete insulin in response to glucose, they secrete nearly normal amounts of insulin in response to feeding. Because Sur1 null mice lack an insulin secretory response to GLP-1, even though their islets exhibit a normal rise in cAMP by GLP-1, we tested their response to cholinergic stimulation. We found that perfused Sur1 null pancreata secreted insulin in response to the cholinergic agonist carbachol in a glucose-dependent manner. Together, these findings suggest that cholinergic stimulation is one of the mechanisms that compensate for the severely impaired response to glucose and GLP-1 brought on by the absence of Sur1, thereby allowing euglycemia to be maintained.Glucose-stimulated insulin secretion by the pancreatic  cell requires the coupling of changes in glucose metabolism to alterations in membrane potential (1-4). In response to a rise in the intracellular ATP/ADP ratio that occurs with glucose metabolism the closure of ATP-sensitive potassium (K ATP ) 1 channels causes the  cell membrane to depolarize. This, in turn, leads to the opening of voltage-gated L-type Ca 2ϩ channels, a rise in the cytoplasmic free Ca 2ϩ concentration ([Ca 2ϩ ] i ), and the subsequent exocytosis of insulin (5). The  cell K ATP channel is an octameric complex of two proteins: an inward-rectifier K ϩ channel, Kir6.2, and the sulfonylurea receptor type 1 (Sur1), which are present in a 4:4 stoichiometry (6, 7). Kir6.2, which forms the channel pore, possesses intrinsic ATP sensitivity (8, 9), whereas Sur1, a member of a superfamily of ATPbinding cassette transporter proteins, provides sites for interaction with Mg-ADP (10). Sulfonylureas, which are widely used for treatment of patients with type 2 diabetes mellitus, act by binding to K ATP channels and stimulating their closure (10).Mutations in Sur1 are a frequent cause of persistent hyperinsulinemic hypoglycemia of infancy (PHHI), an autosomal recessive disorder characterized by excess and unregulated secretion of insulin. Because initial identification of Sur1 as a candidate gene for PHHI by , more than 50 different mutations in this gene, as well as 2 mutations in Kir6.2, have been identified in PHHI patients (12). Analyses of pancreatic  cells from PHHI patients, as well as functional studies of mutated K ATP channels introduced into cultured cells, suggest that impaired K ATP channel...